HTAs and rare diseases: How to assess their cost-effectiveness

Phillips, C.J. and Hughes, D.A. (2011) HTAs and rare diseases: How to assess their cost-effectiveness. Pharmaceuticals Policy and Law, 13 ((3-4)). pp. 161-165. DOI: 10.3233/PPL-2011-0321

Full-text not available from this repository..
Item Type: Article
Subjects: Research Publications
Departments: College of Health and Behavioural Sciences > Institute of Medical & Social Care Research
Date Deposited: 09 Dec 2014 16:59
Last Modified: 23 Sep 2015 03:19
ISSN: 1389-2827
URI: http://e.bangor.ac.uk/id/eprint/1704
Identification Number: DOI: 10.3233/PPL-2011-0321
Publisher: Unknown
Administer Item Administer Item

eBangor is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.